Suppr超能文献

术前癌胚抗原与淋巴细胞比值作为老年结直肠癌患者的预后预测指标:一项多中心回顾性研究

Preoperative carcinoembryonic antigen to lymphocyte ratio serves as a prognostic predictor in elderly patients with colorectal cancer: a multicentre retrospective study.

作者信息

Liang Tao, Jiang Jiayi, Li Xinyi, Ma Haohan, Zhang Xiaonan, Deng Gang, Deng Weiping, Guan Lichang, Zhang Kaijun, Jiang Lei, Tan Ning, Cai Xujie, Xu Lishu

机构信息

Department of General Surgery (Area 1), People's Hospital of Yingde City, Yingde, Guangdong, China.

Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.

出版信息

BMJ Open. 2025 Jan 20;15(1):e086432. doi: 10.1136/bmjopen-2024-086432.

Abstract

OBJECTIVES

The aim of this study is to derive and validate a reliable indicator for predicting an increased risk of postoperative mortality in elderly patients undergoing curative resection for colorectal cancer (CRC).

DESIGN

This study is of multicentre retrospective design.

SETTING AND PARTICIPANTS

A total of 1227 CRC patients undergoing curative resection (age ≥65 years) from three distinct cohorts were retrospective enrolled. Participant cohorts consisted of the derivation (n=845), external validation (n=95) and localised validation (n=287) groups. The carcinoembryonic antigen (CEA) to lymphocyte ratio (CLR) was derived from the derivation cohort and subsequently validated in two additional cohorts. The observed end point was all-cause death during the follow-up period postoperation.

RESULTS

In the derivation cohort, CLR demonstrated an independent association with all-cause mortality. In the two validation cohorts, CLR also presented a strong discriminatory ability in predicting postoperative all-cause death, with the area under the curve (AUC) of 0.68 in the external cohort and 0.78 in the localised cohort. Survival analyses revealed that CRC patients with CLR ≤2.53 tended to have better overall survival than those with CLR >2.53 (p<0.05 for all cohorts). Multivariate Cox proportional hazard models indicated that CLR ≤2.53 was significantly associated with reduced mortality risk in the derivation (HR: 0.405, p<0.001), external validation (HR: 0.519, p=0.039) and localised validation cohorts (HR: 0.167, p<0.001).

CONCLUSIONS

Preoperative CLR serves as a reliable predictor of all-cause death following curative resection in elderly patients with CRC. Individuals with CLR exceeding 2.53 are inclined to a lower overall survival probability.

摘要

目的

本研究旨在推导并验证一个可靠指标,以预测接受结直肠癌(CRC)根治性切除术的老年患者术后死亡风险增加。

设计

本研究为多中心回顾性设计。

设置与参与者

从三个不同队列中回顾性纳入了1227例行根治性切除术的CRC患者(年龄≥65岁)。参与者队列包括推导组(n = 845)、外部验证组(n = 95)和局部验证组(n = 287)。癌胚抗原(CEA)与淋巴细胞比值(CLR)从推导队列中得出,随后在另外两个队列中进行验证。观察终点为术后随访期间的全因死亡。

结果

在推导队列中,CLR显示出与全因死亡率独立相关。在两个验证队列中,CLR在预测术后全因死亡方面也具有很强的鉴别能力,外部队列的曲线下面积(AUC)为0.68,局部队列的AUC为0.78。生存分析显示,CLR≤2.53的CRC患者总体生存率往往高于CLR>2.53的患者(所有队列p<0.05)。多变量Cox比例风险模型表明,CLR≤2.53与推导组(HR:0.405,p<0.001)、外部验证组(HR:0.519,p = 0.039)和局部验证队列(HR:0.167,p<0.001)的死亡风险降低显著相关。

结论

术前CLR可作为老年CRC患者根治性切除术后全因死亡的可靠预测指标。CLR超过2.53的个体总体生存概率较低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e61/11751927/1aa231652c39/bmjopen-15-1-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验